FDA commissioner suggests RFK Jr. and Trump might compromise an agency ‘at peak performance’
The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s hostility to civil servants, Califf said. Trump has said he plans to give Kennedy, leader of the “Make America Healthy Again” movement, power over health care policy in his administration.
Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...
While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid ...
FDA commissioner Robert Califf’s second term is anticipated to end in 2025, and all eyes are now on who will be the ...
Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered ...
Trump has promised he would allow Robert F. Kennedy Jr. to "go wild" on medicines, food, and health. With that, a radical antiestablishment medical movement with roots in past centuries could threaten ...
At a cancer research event Tuesday, FDA Commissioner Robert Califf said he was “disappointed” with the election results ...
Federal employees are concerned over President-elect Donald Trump’s pick, Robert F. Kennedy Jr., to lead the Department of ...
U.S. Food and Drug Administration Commissioner Robert Califf is unsure about the future of the agency ... “I’m biased, ...
By Samuel Indyk and Ludwig Burger (Reuters) -Shares of major U.S. drugmakers fell on Friday after U.S. President-elect Donald ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback